Livedo-like dermatitis (Nicolau's syndrome) after injection of Copolymer-1 (glatiramer acetate);Dermite livedoïde de Nicolau après injection de Copolymère-1 (acétate de glatiramer)

Revue Neurologique

Volumn 159, Issue 5 I, 2003, Pages 571-573

  Gaudez, C ^a,b   Regnier, S ^a   Aractingi, S ^a   Heinzlef, O ^a  

^a HÔPITAL TENON   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; GLATIRAMER; VASOACTIVE AGENT;

ADULT; ARTICLE; CASE REPORT; DERMATITIS; FEMALE; HUMAN; INJECTION PAIN; ISCHEMIA; MULTIPLE SCLEROSIS; NECROSIS; SKIN MANIFESTATION; THROMBOSIS; VASOSPASM;

ACUTE DISEASE; ADULT; ANTICOAGULANTS; ARM; BRACHIAL ARTERY; DRUG ERUPTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRA-ARTERIAL; ISCHEMIA; MULTIPLE SCLEROSIS; NECROSIS; PAIN; PEPTIDES; SYNDROME;

EID: 0037867853     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BORK K. (1988). Aseptic necrosis after intramuscular injection (embolia cutis medicamentosa). In Saunders W.B. (ed) Cutaneous Side Effects of Drugs. pp. 364-369.
2. BRACHTEL R, MEINERTZ T. (1977). Local skin necrosis after intramuscular injection - Experimental animal studies. Arch Dermatol Res, 258: 281-288.
3. DRAGO F, BRUSATI C, MANCARDI G, MURIALDO A, REBORA A. (1999). Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis. Arch Dermatol, 135: 1277-1278.
4. FAUCHER L, MARCOUX D. (1995). What syndrome is this? Nicolau syndrome. Pediatr Dermatol, 12: 187-190.
5. GERBEAUX J, COUVREUR J, LAJOUANINE P, CANET J, BONVALLET M. (1966). Sur deux cas d'ischémie étendue transitoire après injection intramusculaire de benzathine-pénicilline chez l'enfant. Presse Med, 74: 299-302.
6. JOHNSON KP, BROOKS BR, COHEN JA, et al. (1995). Copolymer-1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double blind, placebo-controlled trial. Neurology, 45: 1268-1276.
7. JOHNSON KP, BROOKS BR, COHEN JA, et al. (1998). Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Neurology, 50: 701-708.
8. KNOWLES JA. (1966). Accidental intra-arteriel injection of penicillin. Am J Dis Child, 111: 552-556.
9. MANCARDI GL, MURIALDO A, DRAGO F, BRUSATI C, CROCE R, INGLESE M, RATTO S. (2000). Localized lipoatrophy after prolonged treatment with Copolymer-1. J Neurol, 247: 220-221.
10. MARIE J, LEVÊQUE B, DEBAUCHEZ C, BANGEMANN G. (1964). Accident hémorragique et nécrotique loco-régional à la suite d'une injection de benzhatine-pénicilline. Ann Pédiatrie, 40: 2517.
11. MÜLLER-VAHL H. (1983). Adverse reactions after intra-muscular injections. Lancet, 1: 1050.
12. MÜLLER-VAHL H, PABST R. (1984). An animal model for aseptic necroses after intramuscular injection. Int J Tissue React, 6: 251-254.
13. NAGORE E, TORRELO A, GONZALEZ-MEDIERO I, ZAMBRANO A. (1997). Livedoid skin necrosis (Nicolau Syndrome) due to triple vaccine injection. Br J Dermatol, 137: 1030-1031.
14. NICOLAU S. (1925). Dermite livédoide et gangréneuse de la fesse consécutive aux injections intramusculaires dans la syphilis. Ann Mal Ven, 20: 321-339.
15. RUFFIEUX P, SALOMON D, SAURAT JH. (1996). Livedo-like dermatitis (Nicolau's syndrome): a review of three cases. Dermatology, 193: 368-371.
16. STRICKER BHC, VAN KASTEREN BJ. (1992). Diclofenac-induced isolated myonecrosis and the Nicolau syndrome. Ann Intern Med, 117: 1058.
17. SVENDSEN O. (1983). Intramuscular injections and local muscle damage: an experimental study of the effect of injection speed. Acta Pharmacol toxicol, 52: 305-309.
18. TALBERT JL, HASLAM RH, HALLER JA. (1967). Gangrene of the foot following intramuscular injection in the lateral thigh: A case report with recommendations for prevention. J Pediatr, 70: 110-121.
19. VASILESCU N, STAMATOIU I (1965). Le syndrome livédoido-paralytique. Presse Med, 73: 1684-1687.